Biopharmaceuticals, including monoclonal antibodies, recombinant proteins, and gene therapies, represent the frontier of modern medicine. This book examines the development and clinical applications of biopharmaceuticals across various therapeutic areas, such as oncology, autoimmune diseases, and rare genetic disorders. It discusses production technologies, regulatory pathways, and challenges in ensuring affordability and access. This comprehensive guide is indispensable for healthcare professionals and researchers involved in biopharmaceutical innovation.
Mason Soto is a leading dermatologist specializing in the therapeutic applications of biopharmaceuticals in dermatology. His research investigates the use of biologic agents, such as monoclonal antibodies and recombinant proteins, in treating complex skin conditions like psoriasis, atopic dermatitis, and hidradenitis suppurativa. Mason has published extensively on the development, efficacy, and safety of biopharmaceuticals in dermatological therapies, exploring their role in personalized medicine approaches. He has developed comprehensive biopharmaceutical treatment protocols that enhance the management of complex skin conditions.